Price to Sales AnalysisPrice to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
DarioHealth Corp Distress Driver Correlations
Price to Sales PatternReturn on Sales is a ratio to evaluate a company's operational efficiency; calculated by dividing Earning Before Interest and Taxes EBIT by Revenues. ROS is often a component of DuPont return on equity.
About Price to SalesThe most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
|Compare to competition|
DarioHealth Corp Price to Sales Assessment
Based on latest financial disclosure the price to sales indicator of DarioHealth Corp is roughly 4.18 times. This is 80.44% lower than that of the Healthcare sector, and significantly higher than that of Medical Equipment industry, The Price to Sales for all stocks is 76.53% higher than the company.